Full-Service
Intellectual Property
Law Firm
We assist our clients – both large and small – in all IP matters globally. We are your partner in business growth and development.
Contact usOur clients
Our services
Patents
We help protect your innovations and business - patents prevent competitors from copying your invention and improve your company's market position.
Brands & Designs
We expertly identify and protect your brand, design, and domain names as IP assets that add value to your business.
IP Consulting
Effective management of intellectual property rights creates a competitive advantage and protects a company's innovations and brand in the market.
Brokerage
We help you identify the commercialization opportunities of your IP assets and offer tailored solutions for their monetization.
Berggren is a Full-Service European IP Law Firm
For over 85 years, Berggren has been at the forefront of protecting and utilizing intellectual property rights. As an internationally recognized IP expert organization, we offer comprehensive services in the management of patents, trademarks, design protection, and domain names, as well as their commercial exploitation. Additionally, we provide extensive expertise in business law services.
Our service range is aimed globally at entities of all sizes. By combining our diverse services and in-depth expertise, we create customized and effective solutions for our clients' unique intellectual property needs.
Blogs & News
IP Diagnosis: Is my medical invention patentable? Part 7 - Treatment by therapy
Learn about the patentability of medical inventions, specifically focusing on treatment by surgery. Understand the criteria for determining...
Read moreTo be or not to be (obvious), that is the question
Expert analysis on a recent IP court decision regarding inventive step in patent law. Learn how the FCJ's "could-would approach" impacts IP...
Read moreGerman Federal Court of Justice inches closer to EPO approach to novelty and applies EPO’s standard on priority claims from G1/22 and G2/22
Explore how the German Federal Court of Justice aligns with the EPO's approach to novelty and priority claims in the landmark Sorafenib-Tosylat case.
Read moreHow can we help?
If you have any questions or would like to give feedback, our team is ready to help!
Contact us